|
Volumn 354, Issue 12, 2006, Pages 1310-1312
|
Protease variants, LDL, and coronary heart disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN B;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
KEXIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN RECEPTOR;
LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;
MESSENGER RNA;
PCSK9 ENZYME;
PROTEINASE;
STEROL REGULATORY ELEMENT BINDING PROTEIN;
SUBTILISIN;
UNCLASSIFIED DRUG;
ATHEROSCLEROSIS;
CARDIOVASCULAR RISK;
CELL MEMBRANE;
CHOLESTEROL BLOOD LEVEL;
CHOLESTEROL METABOLISM;
EDITORIAL;
FAMILIAL HYPERCHOLESTEROLEMIA;
GENE MUTATION;
HUMAN;
ISCHEMIC HEART DISEASE;
MISSENSE MUTATION;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
UPREGULATION;
ANIMALS;
CHOLESTEROL, LDL;
CODON, NONSENSE;
CORONARY DISEASE;
GENE EXPRESSION REGULATION;
HUMANS;
HYPERLIPOPROTEINEMIA TYPE II;
HYPOLIPOPROTEINEMIAS;
MICE;
MUTATION, MISSENSE;
RECEPTORS, LDL;
SERINE ENDOPEPTIDASES;
VARIATION (GENETICS);
|
EID: 33645098219
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMe068026 Document Type: Editorial |
Times cited : (34)
|
References (5)
|